Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

EU grants CE mark to Medi-tate BPH device

The European Union (EU) has granted a CE mark certification to Medi-tate's benign prostate hyperplasia (BPH) device.

The BPH device is a minimally invasive procedure which is designed to reshape the urethra, reports.

Medi-tate provides solution to patients and urologists, achieving surgery-like results using a minimally invasive office procedure and avoiding traumatic tissue cutting, heavy sedation and hospitalization.

Medi-tate said 5 million American men have BPH symptom, only one fifth of whom are treated, and one tenth of them by surgery.